Genepoint Technologies Co., Ltd.
PrivateLast Round
Series D
Jan 18, 2023
Total Funding Raised
$67.15M
Company Overview
Genepoint Technologies Co., Ltd. is a biotechnology company that develops and manufactures automated cryogenic storage and handling systems for life sciences research and biobanking.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Warehouse Automation, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genepoint Technologies Co., Ltd. Comparables
Compare Genepoint Technologies Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Origincell Biological Cryo Equipment Co., Ltd. | 89% | |
| Origincell Technology Group | 89% | |
| Shanghai iKelvin Life Science & Technology Co., Ltd. | 85% |
Genepoint Technologies Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jan 18, 2023 | ||||
| Series C Extension | Feb 7, 2022 | ||||
| Series C Extension | Jul 12, 2021 | ||||
| Series C | Jun 9, 2021 | ||||
| Series B | Oct 31, 2019 | ||||
Series A | Aug 24, 2018 |
Genepoint Technologies Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series D, Series C, Series C Extension |
| Hosencare Brothers | Series C |
| Bangming Capital | Angel |
| Zhongke Guosheng | Series D |
| Day One Capital | Series D, Series C, Series C Extension |
| Northern Light Venture Capital | Series C |
| LYFE Capital | Series D, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 18, 2023
$30M round led by Guofang Capital
- Feb 7, 2022
$19M round led by LYFE Capital, Day One Capital, and DYEE Capital.
Genepoint Technologies Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genepoint Technologies Co., Ltd.'s valuation, stock price, and market status.
Is Genepoint Technologies Co., Ltd. a public or private company?
Genepoint Technologies Co., Ltd. is a private company.
What is the current stock price of Genepoint Technologies Co., Ltd.?
Genepoint Technologies Co., Ltd. is a private company with no public stock price. Caplight tracks Genepoint Technologies Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Genepoint Technologies Co., Ltd. worth (valuation)?
Valuation information for Genepoint Technologies Co., Ltd. is not publicly available.
Can I buy Genepoint Technologies Co., Ltd. stock?
Genepoint Technologies Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genepoint Technologies Co., Ltd.'s last funding round?
Genepoint Technologies Co., Ltd.'s most recent funding round was Series D on January 18, 2023.
Who are the main investors in Genepoint Technologies Co., Ltd.?
Key investors in Genepoint Technologies Co., Ltd. include DYEE Capital, Hosencare Brothers, Bangming Capital, Day One Capital, Northern Light Venture Capital.
Will Genepoint Technologies Co., Ltd. IPO soon?
No public IPO plans have been announced for Genepoint Technologies Co., Ltd..
How can I track Genepoint Technologies Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genepoint Technologies Co., Ltd.'s secondary market activity and sign up for updates.